Bill Gantz

PathoGenesis Corporation

Prior to joining Ovation Pharmaceuticals, Inc. in 2002, Bill Gantz was the Chairman, CEO and President of PathoGenesis Corporation (“PathoGenesis”), a publicly traded biopharmaceutical company focused on developing and marketing novel pharmaceutical products to treat serious chronic human infectious diseases. Under Mr. Gantz’s leadership, PathoGenesis was sold to Chiron Corporation in September 2000. Prior to his tenure with PathoGenesis, Mr. Gantz was president of Baxter International from 1987 to 1992. During his 25-year career with Baxter, he held a number of senior leadership positions, including Executive Vice President and COO.